SurgoCap Partners LP

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$3.04B2026 Q3
Positions11
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.96.3%

SurgoCap Partners LP reported 11 positions worth $3.04B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: TSM (16.3%). Biggest move: exit GOOG ($341.3M).

10 / 11 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 TSMTaiwan Semiconductor$495.1M16.27%1,085,185——-18.1%
▸ 2 MCKMckesson$493.1M16.21%577,584——+29.4%
▸ 3 LPLALPL Financial$349.2M11.48%1,141,781——-5.1%
▸ 4 CRSCarpenter Technology$319.6M10.50%821,880——-28.3%
▸ 5 MSFTMicrosoft$294.1M9.67%573,423——+1.0%
▸ 6 INTCIntel$252.3M8.29%2,098,348——-53.9%
▸ 7 MDLNMedline$228.2M7.50%6,575,970——+12.9%
▸ 8 VVisa$216.3M7.11%601,988——+18.7%
▸ 9 HLTHilton Worldwide$165.6M5.44%520,612——+17.5%
▸ 10 MELIMercadolibre$116.4M3.83%67,356——-15.4%

Pro Feature

The remaining 1 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does SurgoCap Partners LP hold as of Q3 2026?

SurgoCap Partners LP reported 11 positions worth $3.04B in its Q3 2026 13F filing. Largest positions: TSM (16.3%), MCK (16.2%), LPLA (11.5%), CRS (10.5%) and MSFT (9.7%).

What did SurgoCap Partners LP buy in Q3 2026?

New positions: MSFT, HLT and MELI. Added to: MCK, TSM, CRS, INTC and LPLA (7 in all).

What did SurgoCap Partners LP sell in Q3 2026?

Reduced: MDLN. Sold out entirely: GOOG, GLW, AGX, ISRG and DPC.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.